Abstract
A simple and sensitive spectrofluorimetric method has been developed and validated for determination of oseltamivir phosphate (OSP). The proposed method is based on condensation reaction of the primary amino group of OSP with ninhydrin and phenylacetaldehyde in buffered medium (pH 6.5). The formed yellow fluorescent product exhibits excitation and emission maxima at 390 and 460 nm, respectively. The selectivity improvement of our proposed method is based on the water insolubility of the oseltamivir carboxylic acid (OSC) the active metabolite of OSP, which contains the same primary amino group as OSP but cannot, condensed with ninhydrin and phenylacetaldehyde reagents. The different experimental parameters affecting the formation and stability of the reaction product were carefully studied and optimized. The fluorescence intensity concentration plot is rectilinear in the range of 2–15 μg ml−1 with detection and quantitation limits of 0.32 and 0.98 μg ml−1, respectively. The proposed method was successfully applied for determination of OSP in commercial capsules, suspension and spiked human plasma with good percentage recovery. In addition, the developed procedure was extended to study the stability of OSP under different stress conditions; including acid and alkali hydrolysis, oxidation, photolysis, and thermal degradation. Furthermore, the kinetic of alkaline and acidic degradation of the cited drug were investigated. The apparent first order degradation rate constants were 0.258 and 0.318 K h−1 with half times of 2.68 and 2.17 h, for acidic and alkaline degradation, respectively.
Similar content being viewed by others
References
Nicholson K, Aoki F, Osterhaus A, Trottier S, Carewicz O, Mercier C, Rode AN, Kinnersley P (2000) Ward, efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Lancet 355:1845–1850
Wiltshire H, Wiltshire B, Citron A, Clarke T, Serpe C, Gray D, Herron W (2000) Development of a high-performance liquid chromatographic–mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine. J Chromatogr B Biomed Sci Appl 745:373–388
Dreitlein WB, Maratos J, Brocavich J (2001) Zanamivir and oseltamivir: two new options for the treatment and prevention of influenza. Clin Ther 23:327–355
McClellan K, Perry CM (2001) Oseltamivir: a review of its use in influenza. Drugs 61:263–283
Ward P, Small I, Smith J, Suter P, Dutkowski R (2005) Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother 55:i5–i21
Green MD, Nettey H, Wirtz RA (2008) Determination of oseltamivir quality by colorimetric and liquid chromatographic methods, emerging infect. Dis 14:552–556
Raut CS, Gharge DS, Dhabale PN, Gonjari ID, Hosmani AH, Hosmani AH (2010) Development and validation of oseltamivir phosphate in Fluvir® by UV spectrophotometer. Int J PharmTech Res 2:363–366
Ashish AT, Rahul JK, Pramila T, Udaykumar AB, Kiran BD (2011) Development, validation and application of UV-spectrophotometric method for the determination of oseltamivir phosphate in bulk and pharmaceutical dosage form. Int J ChemTech Res 3:569–573
Bano T, Yadav G, Dudhe R (2013) Development and validation of oseltamivir phosphate API by UV-spectrophotometer, global J. Pharmacol 7:294–297
Kumar JVS, Prasanthi S, Guravaiah M, Sekaran CB (2012) Application of potassium permanganate to the spectrophotometric determination of oseltamivir phosphate in bulk and capsules. Asian J Pharm Clin Res 5:18–22
Sahu S, Acharya S, Chourasia A, Asati A (2012) Method development and validation of oseltamivir phosphate in bulk drug by UV spectroscopy. Int J Pharm Pharm Sci 4:194–196
Ashish AT, Pramila T (2011) Simple extractive colorimetric determination of oseltamivir phosphate by ion-pair complexation method in bulk and capsule dosage form. Int J Res Pharm Biomed Sci 2:543–547
Narasimhan B, Abida K, Srinivas K (2008) Stability indicating RP-HPLC method development and validation for oseltamivir API. Chem Pharm Bull 56:413–417
Joseph CJ, Geneste C, Laborde-Kummer E, Gheyouche R, Boudis H, Dubost JP (2007) Development and validation of a rapid HPLC method for the determination of oseltamivir phosphate in Tamiflu® and generic versions. J Pharm Biomed Anal 44:1008–1013
Lindegårdh N, Hanpithakpong W, Wattanagoon Y, Singhasivanon P, White NJ, Day NPJ (2007) Development and validation of a liquid chromatographic–tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine. J Chromatogr B 859:74–83
Heinig K, Bucheli F (2008) Sensitive determination of oseltamivir and oseltamivir carboxylate in plasma, urine, cerebrospinal fluid and brain by liquid chromatography–tandem mass spectrometry. J Chromatogr B 876:129–136
Kanneti R, Bhavesh D, Paramar D, Bhatt PA (2011) Development and validation of a high-throughput and robust LC–MS/MS with electrospray ionization method for simultaneous quantitation of oseltamivir phosphate and its oseltamivir carboxylate metabolite in human plasma for pharmacokinetic studies. Biomed Chromatogr 25:727–733
Chan D, Tarbin J, Sharman M, Carson M, Smith M, Smith S (2011) Screening method for the analysis of antiviral drugs in poultry tissues using zwitterionic hydrophilic interaction liquid chromatography/tandem mass spectrometry. Anal Chim Acta 700:194–200
Chabai H, Ouarezki R, Guermouche S, Guermouche MH (2011) Rapid determination of oseltamivir phosphate in pharmaceutical preparation using monolithic silica HPLC column. J Liq Chromatogr Relat Technol 34:1913–1924
Kromdijk W, Rosing H, Van den Broek MPH, Beijnen JH, Huitema ADR (2012) Quantitative determination of oseltamivir and oseltamivir carboxylate in human fluoride EDTA plasma including the ex vivo stability using high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. J Chromatogr B 891:57–63
Laborde KE, Gaudin K, Joseph CJ, Gheyouche R, Boudis H, Dubost JP (2009) Development and validation of a rapid capillary electrophoresis method for the determination of oseltamivir phosphate in Tamiflu® and generic versions. J Pharm Biomed Anal 50:544–546
Avramov-Ivić ML, Petrović SD, Mijin DŽ, Drljević-Đurić KM (2011) The qualitative determination of oseltamivir phosphate in tamiflu® capsule by cyclic voltammetry. Hem Ind 65:87–91
Omar M, Mostafa I, Derayea S (2015) Development and validation of stability-indicating spectrofluorometric method for determination of H1N1 antiviral drug (oseltamivir phosphate) in human plasma through Hantzsch reaction. RSC Adv 5:27735–27742
Walash M, Belal F, El-Enany N, El-Maghrabey M (2012) Spectrofluorimetric determination of oseltamivir phosphate through derivatization with o-phthalaldehyde. Application to pharmaceutical preparations with a preliminary study on spiked plasma samples, Luminescence 27:511–518
Aydoğmuş Z (2009) Simple and sensitive spectrofluorimetric method for the determination of oseltamivir phosphate in capsules through derivatization with fluorescamine. J Fluoresc 19:673–679
ICH Harmonized Tripartite Guideline Validation of analytical procedures: text and methodology, Q2(R1) 2005.Current step 4 version, parent guidelines on methodology dated November 6, 1996, incorporated in November 2005
Pesez M, Bartos J (1974) Colorimetric and Fluorimetric analysis of organic compounds and drugs. Marcel Dekker, Inc., New York
Abdellatef HE, Khalil HM (2003) Colorimetric determination of gabapentin in pharmaceutical formulation. J Pharm Biomed Anal 31:209–214
Rahman N, Kashif M (2003) Application of ninhydrin to spectrophotometric determination of famotidine in drug formulations. Farmaco 58:1045–1050
Omar MA, Hammad MA, Nagy DM, Aly AA (2015) Development of spectrofluorimetric method for determination of certain aminoglycoside drugs in dosage forms and human plasma through condensation with ninhydrin and phenyl acetaldehyde. Spectrochim Acta A Mol Biomol Spectrosc 136:1760–1766
Yoe JH, Jones AL (1944) Ind. Eng. Chem Anal 16:111
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Omar, M.A., Derayea, S.M. & Mostafa, I.M. Selectivity Improvement for Spectrofluorimetric Determination of Oseltamivir Phosphate in Human Plasma and in the Presence of Its Degradation Product. J Fluoresc 27, 1323–1330 (2017). https://doi.org/10.1007/s10895-017-2066-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10895-017-2066-6